5-Chlorosalicylamide - CAS 7120-43-6
Catalog: |
BB034328 |
Product Name: |
5-Chlorosalicylamide |
CAS: |
7120-43-6 |
Synonyms: |
5-chloro-2-hydroxybenzamide; 5-chloro-2-hydroxybenzamide |
IUPAC Name: | 5-chloro-2-hydroxybenzamide |
Description: | 5-Chlorosalicylamide (CAS# 7120-43-6) is a useful research chemical. |
Molecular Weight: | 171.58 |
Molecular Formula: | C7H6ClNO2 |
Canonical SMILES: | C1=CC(=C(C=C1Cl)C(=O)N)O |
InChI: | InChI=1S/C7H6ClNO2/c8-4-1-2-6(10)5(3-4)7(9)11/h1-3,10H,(H2,9,11) |
InChI Key: | NNHMQZBVJPQCAK-UHFFFAOYSA-N |
Boiling Point: | 301.6 °C at 760 mmHg |
Density: | 1.447 g/cm3 |
MDL: | MFCD00007980 |
LogP: | 1.84480 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-111116449-A | Novel tryptamine derivative and preparation method and application thereof | 20191122 |
WO-2020252205-A1 | Inhibitors of integrated stress response pathway | 20190612 |
US-2021317102-A1 | Inhibitors of integrated stress response pathway | 20190612 |
KR-102017115-B1 | Pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containing the same as an active ingredient | 20180515 |
KR-20180056603-A | Pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containing the same as an active ingredient | 20180515 |
PMID | Publication Date | Title | Journal |
22154834 | 20120201 | Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis | European journal of medicinal chemistry |
21689976 | 20110901 | Structural, vibrational and quantum chemical investigations on 5-chloro-2-hydroxybenzamide and 5-chloro-2-hydroxybenzoic acid | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
17410517 | 20070401 | Gastroprotective effect and cytotoxicity of labdenamides | Planta medica |
Complexity: | 163 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 171.0087061 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 171.0087061 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 63.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS